PeerView Oncology & Hematology CME/CNE/CPE Video Podcast

Rásarupplýsingar

PeerView Oncology & Hematology CME/CNE/CPE Video Podcast

PeerView Oncology & Hematology CME/CNE/CPE Video Podcast

Höfundur: PVI, PeerView Institute for Medical Education

PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support c...

EN-US Bandaríkin Menntun

Nýlegir þættir

158 þættir
Lynsey P. Teulings, APRN - Ahead of the Immunotherapy Curve in Head and Neck Cancer: Preparing for Expanding Immune Options in Locally Advanced and Recurrent/Metastatic Disease

Lynsey P. Teulings, APRN - Ahead of the Immunotherapy Curve in Head and Neck Cancer: Preparing for Expanding Immune Options in Locally Advanced and Recurrent/Metastatic Disease

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-12-12 23:00:00 01:08:20
Sækja
Karen C. Daily, D.O. - RiskReady: A Systems Approach to Improving the Recognition and Treatment of High-Risk, HR+, HER2- Early Breast Cancer

Karen C. Daily, D.O. - RiskReady: A Systems Approach to Improving the Recognition and Treatment of High-Risk, HR+, HER2- Early Breast Cancer

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-12-12 23:00:00 00:40:01
Sækja
Susana Banerjee, MBBS, MA, FRCP, PhD, Ana Oaknin, MD, PhD - Putting the Puzzle Together in Advanced Ovarian and Cervical Cancers: Translating Evidence Into Practice for Approved and Emerging ADCs

Susana Banerjee, MBBS, MA, FRCP, PhD, Ana Oaknin, MD, PhD - Putting the Puzzle Together in Advanced Ovarian and Cervical Cancers: Translating Evidence Into Practice for Approved and Emerging ADCs

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-12-05 23:00:00 00:36:50
Sækja
Erica L. Mayer, MD, MPH - Risk Assessment and Treatment Initiation: Successfully Jumpstarting the Adjuvant CDK4/6 Inhibitor Treatment Journey in HR+, HER2- EBC

Erica L. Mayer, MD, MPH - Risk Assessment and Treatment Initiation: Successfully Jumpstarting the Adjuvant CDK4/6 Inhibitor Treatment Journey in HR+, HER2- EBC

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-12-03 23:00:00 00:26:40
Sækja
Susana Banerjee, MBBS, MA, FRCP, PhD, Kathleen N. Moore, MD, MS - Harnessing the Power of ADCs in Gynecologic Cancers: Expert Insights for Practice Integration

Susana Banerjee, MBBS, MA, FRCP, PhD, Kathleen N. Moore, MD, MS - Harnessing the Power of ADCs in Gynecologic Cancers: Expert Insights for Practice Integration

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-12-03 23:00:00 00:38:01
Sækja
Angela Lamarca, MD, PhD, MSc - The Power of Personalised Approaches in Advanced CCA: Team-Based Strategies to Individualise Clinical Care

Angela Lamarca, MD, PhD, MSc - The Power of Personalised Approaches in Advanced CCA: Team-Based Strategies to Individualise Clinical Care

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-12-03 23:00:00 00:35:00
Sækja
Erica L. Mayer, MD, MPH - Nurturing Lasting Benefits of Adjuvant CDK4/6 Inhibitor Therapy in High-Risk HR+, HER2- EBC: Best Practices for Patient Education, AE Monitoring and Management, and Enhanced Adherence/Persistence

Erica L. Mayer, MD, MPH - Nurturing Lasting Benefits of Adjuvant CDK4/6 Inhibitor Therapy in High-Risk HR+, HER2- EBC: Best Practices for Patient Education, AE Monitoring and Management, and Enhanced Adherence/Persistence

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-12-03 23:00:00 00:22:27
Sækja
Professor Stephen Johnston, MA, FRCP, PhD - Charting New Paths in the Treatment of ER+, HER2- MBC: Seeking Clarity and Consensus Through Evidence-Aligned Clinical Cases

Professor Stephen Johnston, MA, FRCP, PhD - Charting New Paths in the Treatment of ER+, HER2- MBC: Seeking Clarity and Consensus Through Evidence-Aligned Clinical Cases

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-12-03 23:00:00 01:10:57
Sækja
Yelena Y. Janjigian, MD*, Siva Raja, MD, PhD, FACS - Critical Conversations for Surgeons and Oncologists in Resectable Gastric/GEJ Cancer: Expert Guidance on Integrating Rapidly Evolving Evidence for Immunotherapy Platforms

Yelena Y. Janjigian, MD*, Siva Raja, MD, PhD, FACS - Critical Conversations for Surgeons and Oncologists in Resectable Gastric/GEJ Cancer: Expert Guidance on Integrating Rapidly Evolving Evidence for Immunotherapy Platforms

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-11-20 23:00:00 00:49:48
Sækja
Prof. Nicolas Girard, MD, PhD / Pasi A. Jänne, MD, PhD - Making Precision Decisions for Patients With EGFRm NSCLC: Success Strategies With Targeted Options, Potent Combinations, and Emerging Agents

Prof. Nicolas Girard, MD, PhD / Pasi A. Jänne, MD, PhD - Making Precision Decisions for Patients With EGFRm NSCLC: Success Strategies With Targeted Options, Potent Combinations, and Emerging Agents

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-10-31 23:00:00 01:11:36
Sækja
Nikhil I. Khushalani, MD - The Immunotherapy Story Continues for CSCC: Insights and Evidence on Advances in Resectable and Unresectable Disease

Nikhil I. Khushalani, MD - The Immunotherapy Story Continues for CSCC: Insights and Evidence on Advances in Resectable and Unresectable Disease

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-10-30 23:00:00 00:48:25
Sækja
Paolo Ghia, MD, PhD - The Clock Strikes Innovation in CLL: Upfront Care With Newer, Time-Limited BTKi Combinations

Paolo Ghia, MD, PhD - The Clock Strikes Innovation in CLL: Upfront Care With Newer, Time-Limited BTKi Combinations

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-10-27 23:00:00 00:53:28
Sækja
Prof. Sanjay Popat, FRCP, PhD - The Earlier the Better in Lung Cancer: Multispecialty Guidance on Screening, Diagnosis and Management of Resectable NSCLC

Prof. Sanjay Popat, FRCP, PhD - The Earlier the Better in Lung Cancer: Multispecialty Guidance on Screening, Diagnosis and Management of Resectable NSCLC

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-10-27 23:00:00 00:42:53
Sækja
Komal Jhaveri, MD, FACP - Changing the Scenery in ER+, HER2- MBC With New Oral SERDs and Combinations: Foundations, Evidence, and Practicalities

Komal Jhaveri, MD, FACP - Changing the Scenery in ER+, HER2- MBC With New Oral SERDs and Combinations: Foundations, Evidence, and Practicalities

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-10-03 23:00:00 01:40:14
Sækja
Nitin Jain, MD - Committing to Advances for CLL Care: Conversations on Modern Standards of Care and Next-Gen Innovation

Nitin Jain, MD - Committing to Advances for CLL Care: Conversations on Modern Standards of Care and Next-Gen Innovation

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-10-03 23:00:00 01:03:58
Sækja
Komal Jhaveri, MD, FACP - Visual Exploration of the Evolving Role of Novel Oral SERDs, Other ER-Targeting Therapies, and Rational Combinations in ER+, HER2- MBC

Komal Jhaveri, MD, FACP - Visual Exploration of the Evolving Role of Novel Oral SERDs, Other ER-Targeting Therapies, and Rational Combinations in ER+, HER2- MBC

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-10-03 23:00:00 00:41:32
Sækja
Julie R. Brahmer, MD, MSc, FASCO - Maximizing the Potential and Expanding the Impact of Immunotherapy in Advanced NSCLC

Julie R. Brahmer, MD, MSc, FASCO - Maximizing the Potential and Expanding the Impact of Immunotherapy in Advanced NSCLC

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-10-03 23:00:00 01:01:33
Sækja
Krish Patel, MD - Mapping Therapeutic Directions in DLBCL: Team Strategies for Prognostic Assessment and Implications for Targeted Therapy and Other Innovative Options

Krish Patel, MD - Mapping Therapeutic Directions in DLBCL: Team Strategies for Prognostic Assessment and Implications for Targeted Therapy and Other Innovative Options

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-09-26 23:00:00 00:38:37
Sækja
Haley A. Moss, MD, MBA / Angeles Alvarez Secord, MD, MHSc - Implementing Immuno-Oncology in Gynecologic Cancer Care for Veterans: Expert Insights on Personalized Treatment

Haley A. Moss, MD, MBA / Angeles Alvarez Secord, MD, MHSc - Implementing Immuno-Oncology in Gynecologic Cancer Care for Veterans: Expert Insights on Personalized Treatment

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-09-26 23:00:00 01:00:15
Sækja
Tanios Bekaii-Saab, MD - Playing the Right Sequence in mCRC: Practical Strategies for Integrating Multi-Kinase Inhibitors in Later Lines of Therapy

Tanios Bekaii-Saab, MD - Playing the Right Sequence in mCRC: Practical Strategies for Integrating Multi-Kinase Inhibitors in Later Lines of Therapy

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-09-05 14:00:00 00:31:18
Sækja
Grzegorz (Greg) S. Nowakowski, MD, FASCO - Raising Frontline Expectations in DLBCL: Principles for Refining Upfront Treatment and Addressing Unmet Needs With Modern Antibody-Based Combinations

Grzegorz (Greg) S. Nowakowski, MD, FASCO - Raising Frontline Expectations in DLBCL: Principles for Refining Upfront Treatment and Addressing Unmet Needs With Modern Antibody-Based Combinations

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-08-28 23:00:00 00:36:38
Sækja
Naval Daver, MD, Ghayas Issa, MD - All Rise for Innovation in AML: Processing New Developments With Menin Inhibitors in Challenging AML Subtypes

Naval Daver, MD, Ghayas Issa, MD - All Rise for Innovation in AML: Processing New Developments With Menin Inhibitors in Challenging AML Subtypes

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-08-28 14:00:00 00:36:49
Sækja
Donna D. Catamero, ANP-BC, OCN, CCRC / Joshua Richter, MD, FACP - At the Nexus of Sequential Care in Myeloma: Interprofessional and Patient Perspectives on GPRC5D-Directed Therapies

Donna D. Catamero, ANP-BC, OCN, CCRC / Joshua Richter, MD, FACP - At the Nexus of Sequential Care in Myeloma: Interprofessional and Patient Perspectives on GPRC5D-Directed Therapies

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-08-27 23:00:00 00:35:12
Sækja
Ghassan Abou-Alfa, MD, JD, MBA, PhD (hc) - Immune to the Impossible in Hepatobiliary Malignancies: Expert Insights on Breakthrough Innovations for Immunotherapy Platforms in Advanced-Stage Disease

Ghassan Abou-Alfa, MD, JD, MBA, PhD (hc) - Immune to the Impossible in Hepatobiliary Malignancies: Expert Insights on Breakthrough Innovations for Immunotherapy Platforms in Advanced-Stage Disease

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-08-25 14:00:00 00:29:20
Sækja
Jonathan L. Kaufman, MD - The Power Sequence in RRMM: Collaborative Approaches for Optimizing Sequential Treatment With Cellular and Off-the-Shelf Immunotherapy

Jonathan L. Kaufman, MD - The Power Sequence in RRMM: Collaborative Approaches for Optimizing Sequential Treatment With Cellular and Off-the-Shelf Immunotherapy

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-08-19 23:00:00 00:38:38
Sækja
Sagar Lonial, MD, FACP - 4x4 in Multiple Myeloma: Maintaining Momentum for Delivering Innovative Care in Newly Diagnosed and Relapsed Disease

Sagar Lonial, MD, FACP - 4x4 in Multiple Myeloma: Maintaining Momentum for Delivering Innovative Care in Newly Diagnosed and Relapsed Disease

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-07-21 14:00:00 01:44:34
Sækja
Samuel Cytryn, MD, Yelena Y. Janjigian, MD* - Achieving Excellence in Gastric/GEJ Cancer Care: Multidisciplinary Guidance on Immunotherapy Platforms in Resectable Disease

Samuel Cytryn, MD, Yelena Y. Janjigian, MD* - Achieving Excellence in Gastric/GEJ Cancer Care: Multidisciplinary Guidance on Immunotherapy Platforms in Resectable Disease

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-07-21 14:00:00 00:47:49
Sækja
Prof. Dr. Peter R. Galle - Purpose in Practice for HCC: Delivering Effective Care With Modern Systemic Platforms Across Disease Settings

Prof. Dr. Peter R. Galle - Purpose in Practice for HCC: Delivering Effective Care With Modern Systemic Platforms Across Disease Settings

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-07-11 14:00:00 01:23:29
Sækja
Jacob Sands, MD - Tailwinds of Innovation in SCLC: Exploring the Therapeutic Potential of ADCs

Jacob Sands, MD - Tailwinds of Innovation in SCLC: Exploring the Therapeutic Potential of ADCs

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-07-11 14:00:00 00:17:53
Sækja
"Prof. Wojciech Jurczak, MD, PhD - Staying on Track Toward Better CLL Outcomes: Delivering Effective Sequential Care Guided by Real-World Experience"

"Prof. Wojciech Jurczak, MD, PhD - Staying on Track Toward Better CLL Outcomes: Delivering Effective Sequential Care Guided by Real-World Experience"

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-07-11 14:00:00 01:23:21
Sækja
Heinz-Josef Lenz, MD, FACP - Catalysts for Redefined Care in Colorectal Cancer: Adapting Systemic Therapy Regimens Across Disease Settings

Heinz-Josef Lenz, MD, FACP - Catalysts for Redefined Care in Colorectal Cancer: Adapting Systemic Therapy Regimens Across Disease Settings

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-07-07 14:00:00 01:18:15
Sækja
Joshua Sabari, MD - Precision Matters in NSCLC: Everything You Need to Know About Biomarker Testing and Targeted Therapies

Joshua Sabari, MD - Precision Matters in NSCLC: Everything You Need to Know About Biomarker Testing and Targeted Therapies

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-07-07 14:00:00 01:30:38
Sækja
Tina Cascone, MD, PhD / Heather A. Wakelee, MD, FASCO - Strategies for Immunotherapy Success in NSCLC: How to Incorporate Modern ICI Platforms Across the Disease Continuum

Tina Cascone, MD, PhD / Heather A. Wakelee, MD, FASCO - Strategies for Immunotherapy Success in NSCLC: How to Incorporate Modern ICI Platforms Across the Disease Continuum

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-06-30 14:00:00 01:14:00
Sækja
Prof. Dr. Patrick Schöffski, MPH / Breelyn A. Wilky, MD - Patient-Centric Frameworks in Desmoid Tumors: Integrating Emerging Science on Gamma Secretase Inhibitors for Progressive Disease

Prof. Dr. Patrick Schöffski, MPH / Breelyn A. Wilky, MD - Patient-Centric Frameworks in Desmoid Tumors: Integrating Emerging Science on Gamma Secretase Inhibitors for Progressive Disease

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-06-27 14:00:00 00:35:15
Sækja
Dr. Toby A. Eyre, MBChB, DipMedEd, MRCP, FRCPath, MD - Navigating the Layers of Complexity in R/R B-Cell Cancers: From Clinical Prognosis to Emerging Therapeutic Prospects in CLL/SLL, MCL, and DLBCL

Dr. Toby A. Eyre, MBChB, DipMedEd, MRCP, FRCPath, MD - Navigating the Layers of Complexity in R/R B-Cell Cancers: From Clinical Prognosis to Emerging Therapeutic Prospects in CLL/SLL, MCL, and DLBCL

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-06-24 14:00:00 00:23:21
Sækja
Shilpa Gupta, MD - Adopting Innovation in Bladder Cancer: Aligning the Evidence on Antibody–Drug Conjugates to Inform Treatment Decisions

Shilpa Gupta, MD - Adopting Innovation in Bladder Cancer: Aligning the Evidence on Antibody–Drug Conjugates to Inform Treatment Decisions

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-06-24 14:00:00 00:36:05
Sækja
Naval Daver, MD - Winning GAMBITS Against AML: Guidance on Advances and Medical Breakthroughs with Innovative Targeted Strategies

Naval Daver, MD - Winning GAMBITS Against AML: Guidance on Advances and Medical Breakthroughs with Innovative Targeted Strategies

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-06-24 14:00:00 01:47:15
Sækja
Karim Fizazi, MD, PhD - Mission Possible in Prostate Cancer: Leveraging Genomics, Modern Therapeutics, and Individualized Patient Care

Karim Fizazi, MD, PhD - Mission Possible in Prostate Cancer: Leveraging Genomics, Modern Therapeutics, and Individualized Patient Care

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-06-23 14:00:00 01:27:03
Sækja
Sumanta Kumar Pal, MD, FASCO - RCC Treatment Innovations in Practice: Preparing for Individualized Patient Care

Sumanta Kumar Pal, MD, FASCO - RCC Treatment Innovations in Practice: Preparing for Individualized Patient Care

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-06-23 14:00:00 01:26:50
Sækja
Hussein Tawbi, MD, PhD - Moving the Efficacy Needle With Immunotherapy in Melanoma: Modern Standards and Next-Gen Strategies in Resectable and Unresectable Disease

Hussein Tawbi, MD, PhD - Moving the Efficacy Needle With Immunotherapy in Melanoma: Modern Standards and Next-Gen Strategies in Resectable and Unresectable Disease

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...

2025-06-23 14:00:00 01:30:25
Sækja
0:00
0:00
Episode
home.no_title_available
home.no_channel_info